| scholarly article | Q13442814 |
| P50 | author | Wei Kang | Q56954147 |
| Alvin Ho-Kwan Cheung | Q59690617 | ||
| Shiyan Wang | Q60179860 | ||
| Joanna H M Tong | Q88524942 | ||
| Raymond Wai-Ming Lung | Q98162621 | ||
| Ka Fai To | Q99551275 | ||
| Yujuan Dong | Q114442534 | ||
| Weiqin Yang | Q114442535 | ||
| Jesse C-S Pang | Q114442540 | ||
| Anthony Wing-Hung Chan | Q43139901 | ||
| Alfred S. Cheng | Q44364620 | ||
| P2093 | author name string | Jun Yu | |
| Bin Zhang | |||
| Feng Wu | |||
| Tingting Huang | |||
| Yi Pan | |||
| Jinglin Zhang | |||
| Yuhang Zhou | |||
| Chi Chun Wong | |||
| Wing Po Chak | |||
| P2860 | cites work | Upregulation of miR-130b enhances stem cell-like phenotype in glioblastoma by inactivating the Hippo signaling pathway. | Q52662491 |
| Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control | Q24299106 | ||
| TEAD mediates YAP-dependent gene induction and growth control | Q24336045 | ||
| Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP | Q24594281 | ||
| Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach | Q24633776 | ||
| Emerging role of Hippo pathway in gastric and other gastrointestinal cancers | Q26774473 | ||
| Comprehensive molecular characterization of gastric adenocarcinoma | Q28244985 | ||
| The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data | Q28266682 | ||
| Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal | Q28288215 | ||
| miR-222/VGLL4/YAP-TEAD1 regulatory loop promotes proliferation and invasion of gastric cancer cells | Q29347531 | ||
| Helicobacter pylori infection and the development of gastric cancer | Q29615341 | ||
| Regulation of Hippo pathway by mitogenic growth factors via phosphoinositide 3-kinase and phosphoinositide-dependent kinase-1 | Q30417692 | ||
| miR-375 inhibits the proliferation of gastric cancer cells by repressing ERBB2 expression | Q33706171 | ||
| Functional screening identifies miRNAs influencing apoptosis and proliferation in colorectal cancer | Q33706508 | ||
| SHOX2 is a direct miR-375 target and a novel epithelial-to-mesenchymal transition inducer in breast cancer cells | Q33891236 | ||
| Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer | Q33943271 | ||
| KRAS and YAP1 converge to regulate EMT and tumor survival | Q33946244 | ||
| MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta | Q34103001 | ||
| MicroRNA-375 targets Hippo-signaling effector YAP in liver cancer and inhibits tumor properties. | Q34103666 | ||
| MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2. | Q34120830 | ||
| Heat shock protein 90 inhibition depletes LATS1 and LATS2, two regulators of the mammalian hippo tumor suppressor pathway. | Q34268075 | ||
| let-7b/g silencing activates AKT signaling to promote gastric carcinogenesis. | Q34333720 | ||
| TAZ expression as a prognostic indicator in colorectal cancer | Q34571020 | ||
| MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1. | Q34786558 | ||
| Targeting of YAP1 by microRNA-15a and microRNA-16-1 exerts tumor suppressor function in gastric adenocarcinoma. | Q35127831 | ||
| Downregulation of connective tissue growth factor inhibits the growth and invasion of gastric cancer cells and attenuates peritoneal dissemination | Q35339610 | ||
| Convergent signaling in the regulation of connective tissue growth factor in malignant mesothelioma: TGFβ signaling and defects in the Hippo signaling cascade | Q36304149 | ||
| Hsa-miR-375 is a predictor of local control in early stage breast cancer | Q36668028 | ||
| The emerging role of the hippo pathway in cell contact inhibition, organ size control, and cancer development in mammals | Q37105079 | ||
| Expression of connective tissue growth factor in tumor tissues is an independent predictor of poor prognosis in patients with gastric cancer | Q37240441 | ||
| A ROR1-HER3-lncRNA signalling axis modulates the Hippo-YAP pathway to regulate bone metastasis. | Q37679659 | ||
| Macro-role of microRNA in gastric cancer | Q38020729 | ||
| The emerging role of miR-375 in cancer | Q38156047 | ||
| Snail-regulated MiR-375 inhibits migration and invasion of gastric cancer cells by targeting JAK2. | Q38972399 | ||
| MicroRNA-375 targets PDK1 in pancreatic carcinoma and suppresses cell growth through the Akt signaling pathway | Q39028824 | ||
| MicroRNA-375 inhibits colorectal cancer growth by targeting PIK3CA. | Q39033124 | ||
| Connective tissue growth factor is a positive regulator of epithelial-mesenchymal transition and promotes the adhesion with gastric cancer cells in human peritoneal mesothelial cells | Q39258011 | ||
| MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo | Q39447513 | ||
| miR-375 is activated by ASH1 and inhibits YAP1 in a lineage-dependent manner in lung cancer. | Q39487411 | ||
| MicroRNA-375 inhibits tumour growth and metastasis in oesophageal squamous cell carcinoma through repressing insulin-like growth factor 1 receptor | Q39495719 | ||
| Epigenetic silencing of microRNA-375 regulates PDK1 expression in esophageal cancer | Q39550203 | ||
| Yes-associated protein 1 exhibits oncogenic property in gastric cancer and its nuclear accumulation associates with poor prognosis. | Q39586964 | ||
| Frequent epigenetic inactivation of KIBRA, an upstream member of the Salvador/Warts/Hippo (SWH) tumor suppressor network, is associated with specific genetic event in B-cell acute lymphocytic leukemia. | Q39617678 | ||
| Connective tissue growth factor enhances the migration of gastric cancer through downregulation of E‐cadherin via the NF‐κB pathway | Q39644225 | ||
| Hippo coactivator YAP1 upregulates SOX9 and endows esophageal cancer cells with stem-like properties | Q42030667 | ||
| Connective tissue growth factor autocriny in human hepatocellular carcinoma: oncogenic role and regulation by epidermal growth factor receptor/yes-associated protein-mediated activation | Q42492308 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 2 | |
| P921 | main subject | carcinogenesis | Q1637543 |
| P304 | page(s) | 92 | |
| P577 | publication date | 2018-01-24 | |
| P1433 | published in | Cell Death and Disease | Q2197222 |
| P1476 | title | miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis | |
| P478 | volume | 9 |
| Q64111599 | A novel circular RNA hsa_circ_0008035 contributes to gastric cancer tumorigenesis through targeting the miR-375/YBX1 axis |
| Q57494135 | A positive feedback regulation between long noncoding RNA SNHG1 and YAP1 modulates growth and metastasis in laryngeal squamous cell carcinoma |
| Q92095483 | AMOTL1 enhances YAP1 stability and promotes YAP1-driven gastric oncogenesis |
| Q61807453 | Downregulation of CENPK suppresses hepatocellular carcinoma malignant progression through regulating YAP1 |
| Q58557620 | Downregulation of miR-145-5p in cancer cells and their derived exosomes may contribute to the development of ovarian cancer by targeting CT |
| Q64951868 | FGF18, a prominent player in FGF signaling, promotes gastric tumorigenesis through autocrine manner and is negatively regulated by miR-590-5p. |
| Q99551276 | FGF18-FGFR2 signaling triggers the activation of c-Jun-YAP1 axis to promote carcinogenesis in a subgroup of gastric cancer patients and indicates translational potential |
| Q92592819 | Hippo Pathway in Cancer: Aberrant Regulation and Therapeutic Opportunities |
| Q91584557 | Identification of the lncRNA-miRNA-mRNA network associated with gastric cancer via integrated bioinformatics analysis |
| Q58700826 | Long noncoding RNA MLK7-AS1 promotes ovarian cancer cells progression by modulating miR-375/YAP1 axis |
| Q64103283 | Mechanotransduction and Cytoskeleton Remodeling Shaping YAP1 in Gastric Tumorigenesis |
| Q64230086 | MicroRNA-375 Suppresses the Growth and Invasion of Fibrolamellar Carcinoma |
| Q60912520 | MicroRNA-4458 suppresses migration and epithelial-mesenchymal transition via targeting HMGA1 in non-small-cell lung cancer cells |
| Q58802789 | MicroRNA-6852 suppresses cell proliferation and invasion via targeting forkhead box J1 in gastric cancer |
| Q100512498 | MicroRNAs are involved in the development and progression of gastric cancer |
| Q55415892 | Novel serum microRNAs panel on the diagnostic and prognostic implications of hepatocellular carcinoma. |
| Q92714314 | Overexpression of TEAD4 correlates with poor prognosis of glioma and promotes cell invasion |
| Q84957646 | The Hippo Pathway and Viral Infections |
| Q90720247 | The Long Noncoding RNA MEG3 and its Target miR-147 Regulate JAK/STAT Pathway in Advanced Chronic Myeloid Leukemia |
| Q64951606 | The Role of MicroRNAs in the Regulation of Gastric Cancer Stem Cells: A Meta-Analysis of the Current Status. |
| Q54977387 | YAP/TAZ Activation as a Target for Treating Metastatic Cancer. |
| Q92276323 | YAP/TAZ: a promising target for squamous cell carcinoma treatment |
| Q60050050 | miR-150-5p suppresses tumor progression by targeting VEGFA in colorectal cancer |
| Q92446009 | miR-664a-3p functions as an oncogene by targeting Hippo pathway in the development of gastric cancer |
Search more.